Evidence map›Paper›PMID 21850159›Full record

ArticleMolecular vision2011

Mutations in a novel serine protease PRSS56 in families with nanophthalmos.

Andrew Orr, Marie-Pierre Dubé, Juan C Zenteno, Haiyan Jiang, Geraldine Asselin, Susan C Evans, Aurore Caqueret, Hesham Lakosha, Louis Letourneau, Julien Marcadier and 9 more

Open access · greenAbstract read
In one paragraph

Article in Molecular vision, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Zebrafish: An In Vivo Screening Model to Study Ocular Phenotypes.Translational vision science & technology · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Clinical features of posterior microphthalmic and nanophthalmic eyes.International journal of ophthalmology · 2018
    Article
  18. Novel Myopia Genes and Pathways Identified From Syndromic Forms of Myopia.Investigative ophthalmology & visual science · 2018
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 1 institution in 1 country.

Andrew OrrDepartment of Ophthalmology and Visual Sciences, Dalhousie University, Halifax, Nova Scotia, Canada. aorr@dal.ca
Marie-Pierre Dubé
Juan C Zenteno
Haiyan Jiang
Geraldine Asselin
Susan C Evans
Aurore Caqueret
Hesham Lakosha
Louis Letourneau
Julien Marcadier
Makoto Matsuoka
Christine Macgillivray
Mathew Nightingale
Simon Papillon-Cavanagh
Scott Perry
Sylvie Provost
Mark Ludman
Duane L Guernsey
Mark E Samuels
Dalhousie University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeNanophthalmos is a rare genetic ocular disorder in which the eyes of affected individuals are abnormally small. Patients suffer from severe hyperopia as a result of their markedly reduced axial lengths, but otherwise are capable of seeing well unlike other more general forms of microphthalmia. To date one gene for nanophthalmos has been identified, encoding the membrane-type frizzled related protein MFRP. Identification of additional genes for nanophthalmos will improve our understanding of normal developmental regulation of eye growth.

methodsWe ascertained a cohort of families from eastern Canada and Mexico with familial nanophthalmos. We performed high density microsatellite and high density single nucleotide polymorphism (SNP) genotyping to identify potential chromosomal regions of linkage. We sequenced coding regions of genes in the linked interval by traditional PCR-based Sanger capillary electrophoresis methods. We cloned and sequenced a novel cDNA from a putative causal gene to verify gene structure.

resultsWe identified a linked locus on chromosome 2q37 with a peak logarithm (base 10) of odds (LOD) score of 4.7. Sequencing of coding exons of all genes in the region identified multiple segregating variants in one gene, recently annotated as serine protease gene (PRSS56), coding for a predicted trypsin serine protease-like protein. One of our families was homozygous for a predicted pathogenic missense mutation, one family was compound heterozygous for two predicted pathogenic missense mutations, and one family was compound heterozygous for a predicted pathogenic missense mutation plus a frameshift leading to obligatory truncation of the predicted protein. The PRSS56 gene structure in public databases is based on a virtual transcript assembled from overlapping incomplete cDNA clones; we have now validated the structure of a full-length transcript from embryonic mouse brain RNA.

conclusionsPRSS56 is a good candidate for the causal gene for nanophthalmos in our families.

Indexed as

Serine ProteasesAnimalsBase SequenceCanadaCloning, MolecularCohort StudiesDNA Mutational AnalysisExonsEyeFrizzled-Related ProteinsGenetic LinkageGenotypeGenotyping TechniquesHeterozygoteHomozygoteHumansFrizzled-Related ProteinsMembrane ProteinsMFRP protein, humanPRSS56 protein, humanSerine Proteases

Identifiers

PMID21850159
PMCPMC3137557
OpenAlexW1819286002

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.